A recent study in medulloblastoma has described that Lumican can be specifically located on the periphery of nodules of the low-risk subset of medulloblastoma, but it is absent on the nodules of the most aggressive subtype and frequently associated with metastases [36]. Here, LUM is linked to medulloblastoma.